Corpus Intelligence IC Memo — THE HEART HOSPITAL BAYLOR PLANO 2026-04-26 09:55 UTC
IC Memo — THE HEART HOSPITAL BAYLOR PLANO
Investment Committee Memorandum | TX | 109 beds | Grade B | EBITDA uplift $34.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

THE HEART HOSPITAL BAYLOR PLANO

CCN 670025 | COLLIN, TX | 109 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

THE HEART HOSPITAL BAYLOR PLANO is a 109-bed suburban community hospital in COLLIN, TX with $464.6M in net patient revenue and a 25.7% operating margin. The hospital serves a payer mix of 39.3% Medicare, 0.1% Medicaid, and 60.5% commercial.

Thesis: Turnaround. Our ML models identify $34.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 25.7% to 33.0% (+736bps).

Net Revenue HCRIS$464.6M
Current EBITDA COMPUTED$119.3M
Operating Margin COMPUTED25.7%
Occupancy HCRIS85.6%
Revenue / Bed COMPUTED$4.3M
Net-to-Gross HCRIS30.4%
Distress Probability ML35.4%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
188
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 25.7% places it above the state median. Among 188 size-comparable peers (54-218 beds), the median margin is 2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (54-218), prioritizing same-state peers. 188 hospitals in the comp set.

HospitalStateBedsRevenueMargin
THE HEART HOSPITAL BAYLOR PLAN (Target)TX109$464.6M25.7%
DRISCOLL CHILDRENS HOSPITALTX215$694.3M29.4%
ROUND ROCK HOSPITALTX165$681.4M8.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
MEMORIAL HERMANN KATYTX196$381.4M13.3%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
MEDICAL CITY FORT WORTHTX209$375.9M22.9%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $34.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$9.8M+210bp18mo
Cost to Collect4.5%2.5%$9.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$9.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$5.7M+122bp9mo
Clean Claim Rate88.0%96.0%$297K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$9.8M
Cost to Collect
$9.3M
Denial Rate Reduction
$9.2M
A/R Days Reduction
$5.7M
Clean Claim Rate
$297K
Total EBITDA Uplift$34.2M
Current EBITDA$119.3M
+ RCM Uplift+$34.2M
Pro Forma EBITDA$153.5M
Current Margin25.7%
Pro Forma Margin33.0%
WC Released (1x)$17.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$183.5M$1.13B6.15x43.8%
Base (11x exit)10.0x11.0x$183.5M$1.30B7.09x48.0%
Bull Case9.0x11.0x$165.2M$1.47B8.92x54.9%
Bull (12x exit)9.0x12.0x$165.2M$1.66B10.03x58.6%
Bear Case11.0x10.0x$201.9M$898.2M4.45x34.8%
Bear (11x exit)11.0x11.0x$201.9M$1.05B5.22x39.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 188 hospitals with 54-218 beds
  • Same-state prioritization (n=189)
  • Comp margins: P25=-9.5% / P50=2.4% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.